Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges.
10.3779/j.issn.1009-3419.2025.106.07
- Author:
Pengxu KONG
1
;
Xiaohan CHEN
1
;
Wang LV
1
;
Pinghui XIA
1
;
Luming WANG
1
;
Jian HU
1
Author Information
1. Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, China.
- Publication Type:English Abstract
- Keywords:
Innovative advancements;
Life-cycle management;
Lung neoplasms;
Perioperative therapy;
Surgery;
Surgical approaches
- MeSH:
Humans;
Lung Neoplasms/surgery*
- From:
Chinese Journal of Lung Cancer
2025;28(3):195-200
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against the backdrop of rapid progress in precision medicine, the paradigm of lung cancer treatment is shifting from single traditional therapy to multi-dimensional integration. This article comprehensively reviews the innovations and challenges in lung cancer surgery in 2024, aiming to explore the future development of surgical treatment with colleagues and to improve patients' quality of life and achieve the goal of "cure".
.
